Lente insulin

Lente insulin is a type of insulin that was used in the management of diabetes mellitus. It is a mixture of 30% semilente insulin and 70% ultralente insulin, which gives it an intermediate duration of action. Lente insulin was discontinued in the United States in 2005.

History

Lente insulin was first introduced in the 1950s. It was developed as a longer-acting form of insulin to help people with diabetes maintain stable blood sugar levels throughout the day. Lente insulin was a popular choice for many years due to its intermediate duration of action and relatively low cost.

Composition

Lente insulin is a mixture of two types of insulin: semilente and ultralente. Semilente insulin is a short-acting insulin, while ultralente is a long-acting insulin. The combination of these two types of insulin gives lente insulin its intermediate duration of action.

Use in Diabetes Management

Lente insulin was used in the management of both type 1 and type 2 diabetes. It was typically administered once or twice daily to help control blood sugar levels. Lente insulin was often used in combination with other types of insulin or oral diabetes medications.

Discontinuation

Lente insulin was discontinued in the United States in 2005. The decision to discontinue lente insulin was made by the manufacturer, Eli Lilly and Company, due to declining demand. Since the discontinuation of lente insulin, other types of insulin with similar durations of action, such as NPH insulin, have been used as replacements.

See Also

• Insulin
• Diabetes mellitus
• Type 1 diabetes
• Type 2 diabetes
• NPH insulin

Lente insulin Resources
Latest articles Most recent articles Ongoing trials	Wikipedia